Epidemiological, 2 and morphological3-5 studies have shown that there is an association between intestinal metaplasia and gastric carcinoma, and it has been considered by many to be a possible marker of premalignant change. Intestinal metaplasia is also a common finding in benign disease of the stomach, however, and recent studies have therefore been directed at identifying variants of intestinal metaplasia which may have a more specific association with gastric carcinoma.6-'2
SUMMARY A total of 1412 consecutive cases of endoscopic gastric biopsy, carried out over a four year period, were reviewed and specimens were examined histochemically to determine the prevalence of intestinal metaplasia and its variants. Three types were characterised: complete intestinal metaplasia and two classes of incomplete intestinal metaplasia (type hIa and type Ilb) depending on the absence or presence, respectively, of sulphomucins within mucin secreting columnar cells. Type lIb intestinal metaplasia was significantly more common in patients with gastric carcinoma (p < 0.001) and in those with dysplasia (p < 0.001) than in patients with benign gastric pathology. No such association was found with either type I or type hIa intestinal metaplasia. In addition to those present in the columnar cells of type IIb intestinal metaplasia, sulphomucins were also commonly found in goblet cells of all three types of metaplasia. The presence of sulphomucins in goblet cells, however, was not significantly associated with gastric carcinoma or dysplasia. The significance of the different types of intestinal metaplasia in relation to the pathological findings is discussed.
Epidemiological, 2 and morphological3-5 studies have shown that there is an association between intestinal metaplasia and gastric carcinoma, and it has been considered by many to be a possible marker of premalignant change. Intestinal metaplasia is also a common finding in benign disease of the stomach, however, and recent studies have therefore been directed at identifying variants of intestinal metaplasia which may have a more specific association with gastric carcinoma.6- '2 On the basis of morphological and histochemical studies several variants of intestinal metaplasia have been described, and these findings have been supported by the results of enzyme histochemistry, '3 14 immunofluorescence,'5 and ultrastructural examination. '6-'8 Although there is some variation in the classification of these subtypes of intestinal metaplasia according to different authors, two main groups are identifiable: complete intestinal metaplasia, which is morphologically similar to epithelium of the small bowel, and incomplete intestinal metaplasia, which shows intermediate features of both gastric and small bowel epithelium. Both groups can be further characterised by the presence Accepted for publication 5 February 1985 or absence of large intestinal enzymes and mucins (o-acylated sialomucins and sulphomucins).
Several recent studies show that the presence of sulphated mucins in intestinal metaplasia has a closer association with gastric carcinoma than intestinal metaplasia in general. 6'0'2'9 This being the case, its presence in endoscopic biopsy material might serve as an important marker indicating the need for careful follow up of the patient. The aim of this investigation was to determine the prevalence of intestinal metaplasia and its variants in endoscopic biopsy specimens and to assess the significance of sulphated mucins in intestinal metaplasia in relation to different gastric diseases.
Material and methods
In the four year period between January 1980 and December 1983 a total of 1465 upper gastrointestinal endoscopies with gastric biopsy were carried out at the Royal Liverpool Hospital. Of these, 92 were repeat examinations, but for the purposes of the present study biopsies from each endoscopy were treated as an individual case. The histology of 1412 cases was reviewed; in the remaining 53 cases material was unavailable for examination and these were excluded. In each case haematoxylin and eosin 613 Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa were noted.
Statistical evaluation was performed using the X2 test and Fisher's exact probability test.
Results
An average of 3 5 biopsy specimens was received for each of the 1412 cases examined, of which 53% were antral type gastric mucosa, 28% were body, 6% were transitional, and 7% were cardiac. In the remaining 6% of cases it was not possible to identify the biopsy site. Table 1 shows the distribution of histological findings in the series as a whole and also the prevalence of intestinal metaplasia within each of the disease categories. The six unclassified cases comprised four cases of non-Hodgkin's lymphoma, one case of gastric carcinoid, and one case of smooth muscle tumour.
Intestinal metaplasia, in one or more biopsies, was present in 37% of all the cases examined, and when compared with the whole series it was relatively more common in antral mucosa and less common in body mucosa (Table 2) . No correlation was found between the extent of intestinal metaplasia in the biopsy specimens and the nature of the lesion. Intestinal metaplasia was a common finding in both benign and malignant lesions, but its prevalence was significantly higher (p < 0001) in dysplastic biopsies than in those showing benign disease (Table 1) . Surprisingly, the prevalence of intestinal metaplasia in gastric carcinoma showed no such significant difference. This may be due partly to the fact that of the 135 cases of carcinoma identified 28 (21%) of the specimens consisted of malignant tissue only. Table 3 shows that while no appreciable difference was found between the male to female ratio in the whole series and in the group with intestinal metaplasia, the mean age was significantly higher (p < 0 001) in the latter group. available for study using the high iron diamine/ alcian blue staining technique and these were classified into three types according to the criteria previously described. Examples of each are shown in Figs. 1-3 . Table 3 shows that there is little difference in the male to female ratio between the different types of intestinal metaplasia and, although the mean age of subjects with type Ilb intestinal metaplasia was slightly higher than in other groups, this difference was not significant. Moreover, when the male to female ratios and mean ages were examined in relation to the distribution of intestinal metaplasia and its subtypes in different sites within the stomach no significant differences were found. Complete intestinal metaplasia (type I) was the most common finding, particularly when only focal intestinal metaplasia was present in the section. Incomplete intestinal metaplasia (type IIa and type IIb) was more likely to be present when there was moderate or extensive metaplasia and was, in most cases, found together with type I intestinal metaplasia, which was either adjacent to the type II intestinal metaplasia or was present as a separate focus. In the former instances, the type I intestinal metaplasia was usually found deep in the metaplastic gland, with the type II intestinal metaplasia being more superficially situated. It was also not uncommon to find both types of incomplete intestinal metaplasia present in the same biopsy specimen, although they were usually discrete and affected different, often adjacent, glands. Compared with type I intestinal metaplasia, both types of incomplete intestinal metaplasia were relatively more common in cardiac mucosa and less common in body mucosa (Table 2) . Table 4 shows the distribution of these types of intestinal metaplasia within the different disease categories. Type I intestinal metaplasia is predominant in all categories, and no significant difference was found in its prevalence within each category. Type Ila intestinal metaplasia, although less common than type I, was also a frequent finding, and its high incidence in chronic gastritis and benign ulceration was significant (p < 0.001) when compared with its presence in gastric carcinoma. In contrast, type lIb intestinal metaplasia was found only occasionally (6% of all intestinal metaplasia cases), but Table 4 shows their distribution and prevalence within the different gastric disease categories. Although commonly found in gastritis and benign ulceration, there is a significantly higher prevalence in gastric dysplasia (0.02 < p < 0.01) and gastric carcinoma (p < 0 001). This appears to be due to the inclusion of type Ilb intestinal metaplasia, however, because when all type Ilb cases are excluded no such significant correlation can be found.
Discussion
Intestinal metaplasia is a common finding in gastroscopic biopsy specimens: we have found intestinal metaplasia in 37% of 1412 consecutive cases and, when considered as a single entity, it is clearly of Intestinal metaplasia in endoscopic biopsy specimens ofgastric mucosa little value as a marker of premalignant change. The heterogeneity of intestinal metaplasia has long been recognised, however, '6 21 22 and recently several variants have been reported. Several authors have suggested that some of these variants may have a special part to play in the histogenesis of gastric carcinoma. ' 8 1 23 Incomplete forms of intestinal metaplasia have been described on the basis of mucin69'°and enzyme'314 histochemistry and ultrastructural studies.I'78 Others have reported a colonic type of intestinal metaplasia by showing the presence of o-acylated sialomucins" '°together with sulphomucins'2 within the metaplastic goblet cells. Heilmann and Hopker" described an enterocolic metaplasia, in which sulphomucins are secreted and which appears to be similar to the type Ilb intestinal metaplasia described by Jass"9 and identified in this study.
In this study we have classified intestinal metaplasia into three groups as described by Jass'': complete (type I) and two types of incomplete (type IIa and type IIb) intestinal metaplasia, depending on the presence or absence of sulphomucins in the mucous columnar cells. Type I intestinal metaplasia was a common finding in both benign and malignant gastric disease, and neither type I nor type IIa intestinal metaplasia showed any significant association with carcinoma. Indeed, type Ila intestinal metaplasia appeared to show a positive correlation with benign gastric pathology. In contrast, type lIb intestinal metaplasia, although found much less commonly, was often (41% of type lIb intestinal metaplasia cases) present in association with gastric carcinoma and, when compared with its incidence in chronic gastritis and peptic ulceration, this appeared highly significant. These results are comparable with the findings of others'°'9 and support the suggestion that a variant of intestinal metaplasia showing appreciable sulphomucin secretion may be a premalignant lesion.6" Our results suggest, however, that type lIb intestinal metaplasia shows low sensitivity as a marker of neoplasia since it was present in only 21% of biopsies which contained both cancer and intestinal metaplasia. The incidence of this type of metaplasia is somewhat higher (41%) in cases of gastric dysplasia and it is possible that destruction of areas of type IIb intestinal metaplasia by tumour growth may account for this difference. Inadequate sampling of tissue from the periphery of the tumour might be another explanation.
A further possibility is that type lib intestinal metaplasia is involved in the histogenesis of only one particular subgroup of carcinomas. Several studies which have looked at intestinal metaplasia in gastrectomy specimens containing gastric carcinoma have reported a particular association between sulphomucin positive variants of intestinal metaplasia and carcinomas showing intestinal differentiation when compared with diffuse gastric carcinomas. '0'2 19 Unfortunately, in this study, because of the possibility of sampling error which is inherent in the use of biopsy material, we thought that classification of gastric carcinoma into these two groups was not valid and we are therefore unable to confirm these findings. Of the 52 cases of gastric carcinoma in which intestinal metaplasia was present in the biopsy specimen, however, 23 gastrectomy specimens were available for examination. Of these carcinomas, 15 were classified as intestinal and eight as diffuse (using the criteria of Lauren24); it is of interest to note that in the biopsy material type lIb intestinal metaplasia was found only in association with intestinal carcinomas.
In addition to finding sulphomucins in columnar cells of type Ilb intestinal metaplasia, we found that goblet cells of both complete and incomplete intestinal metaplasia often contained sulphomucins. When we looked at all sulphomucin positive cases of intestinal metaplasia we found that they accounted for almost half of all cases of intestinal metaplasia and were often present in benign lesions. Although sulphomucin positive intestinal metaplasia was more commonly seen in association with carcinoma, this appeared to be due to the inclusion of type lIb intestinal metaplasia cases. These results suggest that the detection .of sulphomucins in goblet cells is of little assistance in the interpretation of intestinal metaplasia in gastric biopsy material. Sipponen et al in 19807 reported a significant association between all sulphomucin positive intestinal metaplasia and gastric carcinoma using matched controls, but the sites of sulphomucin positivity were not defined, although, from the description given, goblet cell staining appeared to predominate.
Sulphomucins are occasionally present in trace amounts in normal gastric mucosa, where they may be found, together with sialomucins, in deep foveolar cells and mucous neck cells of the antrum and body and also in cardiac glands near the oesophago-gastric junction.62527 Their function in normal gastric mucosa is unknown, but as the foveolar cells migrate to the surface acid groups are lost and the content of neutral mucins increases.27 It has been suggested that both metaplastic and normal pit cells originate from stem cells, in the deep pit or isthmus of the gastric gland, which have the capacity for multipotential differentiation. '6 
